ASYMPTOTE GENETIC MEDICINES

Serial Number 98915324
686

Registration Progress

Application Filed
Dec 20, 2024
Under Examination
Approved for Publication
Jul 15, 2025
Published for Opposition
Jul 15, 2025
Registered

Attorney Assistance

Notice of Publication
Due: Aug 14, 2025 29 days

Trademark Image

ASYMPTOTE GENETIC MEDICINES

Basic Information

Serial Number
98915324
Filing Date
December 20, 2024
Published for Opposition
July 15, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
686
Status Date
Jul 15, 2025
Application
Pending
Classes
005

Rights Holder

Asymptote Genetic Medicines, Inc.

03
Address
1295 S. Euclid Ave.
Pasadena, CA 91106

Ownership History

Asymptote Genetic Medicines, Inc.

Original Applicant
03
Pasadena, CA

Asymptote Genetic Medicines, Inc.

Owner at Publication
03
Pasadena, CA

Legal Representation

Attorney
Jonathan Pearce

USPTO Deadlines

Next Deadline
29 days remaining
Notice of Publication
Due Date
August 14, 2025
Extension Available
Until September 14, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

13 events
Date Code Type Description Documents
Jul 15, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 15, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 9, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 13, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 13, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 12, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 12, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 10, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 10, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 10, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 6, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 20, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 20, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Gene therapy products, namely, genetically engineered tissues for transplant purposes; Pharmaceutical preparations for adeno-associated virus delivery to control gene expression and gene replacement; Pharmaceutical preparations for adeno-associated virus to deliver corrective genes, replace defective genes or delivery therapeutic genes

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
GENETIC MEDICINES